Berlin, Germany - Another study of the macrolide antibiotic roxithromycin in the setting of acute myocardial infarction (AMI) has failed to show a benefit in improving survival or reducing the risk of ...

Review the side-effects of Roxithromycin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Roxithromycin (Biorox DPS) is a semi-synthetic macrolide antibiotic, prescribed for respiratory tract, urinary and soft tissue infections. The information provided on this page is intended to serve as ...

Munich, Germany - One month's treatment with roxithromycin slowed the progression of atherosclerosis in patients with cerebrovascular disease in a new study. Although no effect on clinical events was ...

Telangana: In a sharp rebuke underscoring the need for accountability in regulatory action, Justice Jukanti Anil Kumar of the ...

DUBLIN--(BUSINESS WIRE)--The "Roxithromycin Sales, Price Analysis, & Sales Forecast - 2017" report has been added to ResearchAndMarkets.com's offering. Discover the growth trends of Roxithromycin by ...

Roxithromycin, sometimes known as arrow-roxithromycin, is a semi-synthetic macrolide drug that works by interrupting with protein synthesis to stop bacteria from growing. Conjunctivitis, rhinitis, ...

Growing research activities for expanding applications of roxithromycin is projected to fuel the growth of the roxithromycin market over the forecast period. For instance, according to research by ...

Please provide your email address to receive an email when new articles are posted on . For women with preterm pre-labor rupture of membranes, treatment with cefuroxime- vs. ampicillin-roxithromycin ...